BNP PARIBAS FINANCIAL MARKETS - ATOSSA THERAPEUTICS INC ownership

ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 96 filers reported holding ATOSSA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.0%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of ATOSSA THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$23,156
+182.4%
19,459
+327.2%
0.00%
Q1 2024$8,199
+104.6%
4,5550.0%0.00%
Q4 2023$4,008
+19.5%
4,5550.0%0.00%
Q3 2023$3,355
-41.5%
4,5550.0%0.00%
Q2 2023$5,739
+73.8%
4,5550.0%0.00%
Q1 2023$3,302
-35.0%
4,555
-52.6%
0.00%
Q4 2022$5,083
-99.9%
9,6180.0%0.00%
Q3 2022$8,015,000
-59.7%
9,618
-47.2%
0.00%
Q2 2022$19,867,000
-51.9%
18,227
-44.9%
0.00%
Q1 2022$41,328,000
-49.5%
33,062
-35.3%
0.00%
Q4 2021$81,802,000
-7.5%
51,126
+88.4%
0.00%
Q3 2021$88,476,000
+33.5%
27,140
+158.9%
0.00%
Q2 2021$66,253,00010,4830.00%
Other shareholders
ATOSSA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 524,805$572,0000.39%
Laurion Capital Management LP 2,225,800$2,426,0000.04%
Ergoteles LLC 514,600$561,0000.02%
Pinz Capital Management, LP 17,900$20,0000.01%
Alpine Global Management, LLC 37,089$40,0000.01%
Game Plan Financial Advisors, LLC 10,000$11,0000.01%
Spire Wealth Management 100,300$109,0000.00%
Renaissance Technologies 1,989,995$2,169,0000.00%
D. E. Shaw & Co., Inc. 2,279,636$2,485,0000.00%
Y-Intercept (Hong Kong) Ltd 16,912$18,0000.00%
View complete list of ATOSSA THERAPEUTICS INC shareholders